© 1993 Oxford University Press
research-article |
Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
Department of Pharmacology and Toxicology, University of North Dakota School of Medicine 501 North Columbia Road, Grand Forks, ND 58202-9037, USA
2Division of Clinical Pharmacology and Toxicology, Research Institute, Hospital for Sick Children Toronto M5G DC8, Canada
1To whom correspondence should be addressed
A genetic polymorphism at the NAT2 gene locus, encoding for polymorphic N-acetyltransferase (NAT2), segregates individuals into rapid, intermediate or slow acetylator phenotypes. Both rapid and slow acetylator phenotypes have been associated with increased incidence of cancer in certain target organs related to arylamine exposure, suggesting a role for acetylation in both the activation and deactivation of arylamine carcinogens. A second gene (NAT1) encodes for a different acetyltransferase isozyme (NAT1) that is not subject to the classical acetylation polymorphism. In order to assess the relative ability of NAT1 and NAT2 to activate and deactivate arylamine carcinogens, we tested the capacity of recombinant human NAT1 and NAT2, expressed in Escherichia coli XA90 strains DMG100 and DMG200 respectively, to catalyze the N-acetylation (deactivation) and Oacetylation (activation) of a variety of carbocyclic and heterocyclic arylamine carcinogens. Both NAT1 and NAT2 catalyzed the N-acetylation of each of the 17 arylamines tested. Rates of N-acetylation by NAT1 and NAT2 were considerably lower for heterocyclic arylamines such as 2-amino-3-methyl-imidazo[4, 5-f]quinoline (IQ), particularly those (e.g. IQ) with steric hindrance to the exocydic amino group. For carbocyclic arylamines such as 4-aminobiphenyl and ß-naphthylamine, the apparent affinity was significantly (P < 0.05) higher for NAT2 than NAT1. NAT1/NAT2 activity ratios and clearance calculations suggest a significant role for the polymorphic NAT2 in the N-acetylation of carbocyclic arylamine carcinogens. Both NAT1 and NAT2 catalyzed acetyl coenzyme A-dependent O-acetylation of Af-hydroxy-2-aminofluorene and N-hydroxy-4-aminobiphenyl to yield DNA adducts. NAT1 catalyzed paraoxon-resistant, intramolecular N, O-acetyl-transferase-mediated activation of N-hydroxy-2-acetylamiio-fluorene and N-hydroxy-4acetylaminobiphenyl at low rates; catalysis by NAT2 was not readily detectable in the presence of paraoxon. In summary these studies strongly suggest that the human acetylation polymorphism influences both the metabolic activation (O-acetylation) and deactivation (N-acetylation) of arylamine carcinogens via polymorphic expression of NAT2. These findings lend mechanistic support for human epidemiological studies suggesting associations between both rapid and slow acetylator phenotype and cancers related to arylamine exposure.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. A. Jefferson, G. H. Xiao, and D. W. Hein 4-Aminobiphenyl Downregulation of NAT2 Acetylator Genotype-Dependent N- and O-acetylation of Aromatic and Heterocyclic Amine Carcinogens in Primary Mammary Epithelial Cell Cultures from Rapid and Slow Acetylator Rats Toxicol. Sci., January 1, 2009; 107(1): 293 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Hein, J. Bendaly, J. R. Neale, and M. A. Doll Systemic Functional Expression of N-Acetyltransferase Polymorphism in the F344 Nat2 Congenic Rat Drug Metab. Dispos., December 1, 2008; 36(12): 2452 - 2459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Lakshmi, F. F. Hsu, and T. V. Zenser N-Demethylation Is a Major Route of 2-Amino-3-Methylimidazo[4,5-f]quinoline Metabolism in Mouse Drug Metab. Dispos., June 1, 2008; 36(6): 1143 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Liu, P.-Y. Hsiao, C.-C. Lee, J.-A. Lee, and H.-Y. Chen NAT2*7 Allele Is a Potential Risk Factor for Adult Brain Tumors in Taiwanese Population Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 661 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jiao, M. A. Doll, D. W. Hein, M. L. Bondy, M. M. Hassan, J. E. Hixson, J. L. Abbruzzese, and D. Li Haplotype of N-Acetyltransferase 1 and 2 and Risk of Pancreatic Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2379 - 2386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Walraven, M. A. Doll, and D. W. Hein Identification and Characterization of Functional Rat Arylamine N-Acetyltransferase 3: Comparisons with Rat Arylamine N-Acetyltransferases 1 and 2 J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 369 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lilla, E. Verla-Tebit, A. Risch, B. Jager, M. Hoffmeister, H. Brenner, and J. Chang-Claude Effect of NAT1 and NAT2 Genetic Polymorphisms on Colorectal Cancer Risk Associated with Exposure to Tobacco Smoke and Meat Consumption Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 99 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, J. C. Lambert, M. A. Doll, J. M. Walraven, G. E. Arteel, and D. W. Hein 4,4'-Methylenedianiline-Induced Hepatotoxicity Is Modified by N-Acetyltransferase 2 (NAT2) Acetylator Polymorphism in the Rat J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 289 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Hurley, L. J. Engle, J. T. Davis, A. M. Welsh, and J. E. Landers A simple, bead-based approach for multi-SNP molecular haplotyping Nucleic Acids Res., January 6, 2005; 32(22): e186 - e186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Summerscales and P. D. Josephy Human Acetyl CoA:Arylamine N-Acetyltransferase Variants Generated by Random Mutagenesis Mol. Pharmacol., January 1, 2004; 65(1): 220 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tsuneoka, T. P. Dalton, M. L. Miller, C. D. Clay, H. G. Shertzer, G. Talaska, M. Medvedovic, and D. W. Nebert 4-Aminobiphenyl-Induced Liver and Urinary Bladder DNA Adduct Formation in Cyp1a2(-/-) and Cyp1a2(+/+) Mice J Natl Cancer Inst, August 20, 2003; 95(16): 1227 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Sugamori, S. Wong, A. Gaedigk, V. Yu, H. Abramovici, R. Rozmahel, and D. M. Grant Generation and Functional Characterization of Arylamine N-Acetyltransferase Nat1/Nat2Double-Knockout Mice Mol. Pharmacol., July 1, 2003; 64(1): 170 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chang-Claude, S. Kropp, B. Jager, H. Bartsch, and A. Risch Differential Effect of NAT2 on the Association between Active and Passive Smoke Exposure and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 698 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, G. Liu, S. W. Thurston, L. L. Xu, D. P. Miller, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Genetic Polymorphisms in N-acetyltransferase-2 and Microsomal Epoxide Hydrolase, Cumulative Cigarette Smoking, and Lung Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 15 - 21. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Fronhoffs, T. Bruning, E. Ortiz-Pallardo, P. Brode, B. Koch, V. Harth, A. Sachinidis, H. M. Bolt, C. Herberhold, H. Vetter, et al. Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, *10, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck Carcinogenesis, September 1, 2001; 22(9): 1405 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Deloménie, S. Fouix, S. Longuemaux, N. Brahimi, C. Bizet, B. Picard, E. Denamur, and J.-M. Dupret Identification and Functional Characterization of Arylamine N-Acetyltransferases in Eubacteria: Evidence for Highly Selective Acetylation of 5-Aminosalicylic Acid J. Bacteriol., June 1, 2001; 183(11): 3417 - 3427. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. C. Semenza, A. Ziogas, J. Largent, D. Peel, and H. Anton-Culver Gene-Environment Interactions in Renal Cell Carcinoma Am. J. Epidemiol., May 1, 2001; 153(9): 851 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Seow, B. Zhao, E. J.D. Lee, W.-T. Poh, M. Teh, P. Eng, Y.-T. Wang, W.-C. Tan, and H.-P. Lee Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore Carcinogenesis, April 1, 2001; 22(4): 673 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Fretland, U. S. Devanaboyina, Y. Feng, M. A. Leff, G. H. Xiao, S. J. Webb, and D. W. Hein Oral Administration of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Yields PhIP-DNA Adducts but Not Tumors in Male Syrian Hamsters Congenic at the N-acetyltransferase 2 (NAT2) Locus Toxicol. Sci., February 1, 2001; 59(2): 226 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M-W Yu, C-I Pai, S-Y Yang, T-J Hsiao, H-C Chang, S-M Lin, Y-F Liaw, P-J Chen, and C-J Chen Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk Gut, November 1, 2000; 47(5): 703 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sim, M. Payton, M. Noble, and R. Minchin An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes Hum. Mol. Genet., October 1, 2000; 9(16): 2435 - 2441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Deitz, W. Zheng, M. A. Leff, M. Gross, W.-Q. Wen, M. A. Doll, G. H. Xiao, A. R. Folsom, and D. W. Hein N-Acetyltransferase-2 Genetic Polymorphism, Well-done Meat Intake, and Breast Cancer Risk among Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 905 - 910. [Abstract] [Full Text]
|
|
|
|
|
|
J.A. Williams, F.L. Martin, G.H. Muir, A. Hewer, P.L. Grover, and D.H. Phillips Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue Carcinogenesis, September 1, 2000; 21(9): 1683 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Morabia, M. S. Bernstein, I. Bouchardy, J. Kurtz, and M. A. Morris Breast Cancer and Active and Passive Smoking: The Role of the N-Acetyltransferase 2 Genotype Am. J. Epidemiol., August 1, 2000; 152(3): 226 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Probst-Hensch, D. A. Bell, M. A. Watson, P. L. Skipper, S. R. Tannenbaum, K. K. Chan, R. K. Ross, and M. C. Yu N-Acetyltransferase 2 Phenotype but not NAT1*10 Genotype Affects Aminobiphenyl-Hemoglobin Adduct Levels Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 619 - 623. [Abstract] [Full Text]
|
|
|
|
|
|
V. A. Smelt, A. Upton, J. Adjaye, M. A. Payton, S. Boukouvala, N. Johnson, H. J. Mardon, and E. Sim Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos Hum. Mol. Genet., April 12, 2000; 9(7): 1101 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Delfino, R. Sinha, C. Smith, J. West, E. White, H. J. Lin, S.-Y. Liao, J. S.Y. Gim, H. L. Ma, J. Butler, et al. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype Carcinogenesis, April 1, 2000; 21(4): 607 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Hein, M. A. Doll, A. J. Fretland, M. A. Leff, S. J. Webb, G. H. Xiao, U.-S. Devanaboyina, N. A. Nangju, and Y. Feng Molecular Genetics and Epidemiology of the NAT1 and NAT2 Acetylation Polymorphisms Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 29 - 42. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Dunning, C. S. Healey, P. D. P. Pharoah, M. D. Teare, B. A. J. Ponder, and D. F. Easton A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 843 - 854. [Abstract] [Full Text]
|
|
|
|
|
|
A. Seow, B. Zhao, W.-T. Poh, M. Teh, P. Eng, Y.-T. Wang, W.-C. Tan, E. J.D. Lee, and H.-P. Lee NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore Carcinogenesis, September 1, 1999; 20(9): 1877 - 1881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Leff, P. N. Epstein, M. A. Doll, A. J. Fretland, U.-S. Devanaboyina, T. D. Rustan, and D. W. Hein Prostate-Specific Human N-Acetyltransferase 2 (NAT2) Expression in the Mouse J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 182 - 187. [Abstract] [Full Text]
|
|
|
|
|
|
W. Zheng, A. C. Deitz, D. R. Campbell, W.-Q. Wen, J. R. Cerhan, T. A. Sellers, A. R. Folsom, and D. W. Hein N-Acetyltransferase 1 Genetic Polymorphism, Cigarette Smoking, Well-Done Meat Intake, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 1999; 8(3): 233 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Hickman, J Pope, S D Patil, G Fakis, V Smelt, L A Stanley, M Payton, J D Unadkat, and E Sim Expression of arylamine N-acetyltransferase in human intestine Gut, March 1, 1998; 42(3): 402 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Pool, M. D. Reily, S. M. Bjorge, and T. F. Woolf Metabolic Disposition of the Cognition Activator Tacrine in Rats, Dogs, and Humans. Species Comparisons Drug Metab. Dispos., May 1, 1997; 25(5): 590 - 597. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. F. Trump Mechanisms of Toxicity and Carcinogenesis Toxicol Pathol, November 1, 1995; 23(6): 775 - 827. [PDF]
|
|